Regular Article
Intraoperative Autologous Transfusion during Elective Infrarenal Aortic Reconstruction

https://doi.org/10.1006/jsre.1996.4971Get rights and content

Abstract

Intraoperative autologous transfusion devices have been purported to reduce allogenic transfusions and their associated complications. However, the value of their routine use during elective cardiovascular operations remains undefined. This study was designed to examine the efficacy of the Haemonetics Cell Saver (CS) during elective aortic reconstructions and identify predictors of clinically significant (≥500 cc) and cost-efficient (≥1250 cc) salvage volumes. The medical records of all patients undergoing elective infrarenal aortic reconstructions between January 1991 and June 1995 were retrospectively reviewed to determine blood loss, CS return, predictors of clinically significant/cost-efficient CS returns, blood products transfused, and estimated cost per unit CS return. The CS was used for 138 (82.1%) of all reconstructions during the study period. Estimated blood loss (2127 ± 1467 vs 1415 ± 1047) and CS return (927 ± 790 vs 515 ± 408) were significantly greater in patients with aneurysms (AAA,N= 63) compared to those with aortoiliac occlusive disease (AIOD,N= 75). CS returns ≥500 cc were common (79.4% AAA, 52.0% AIOD) and predictors of ≥500 cc CS returns were large aneurysms (6.79 ± 1.84 vs 5.72 ± 0.71 cm) and male sex (82.0 vs 46.2%) in AAA patients and lower preoperative platelet counts (262 ± 93 vs 311 ± 113 K/mm3), concomitant renal revascularizations (20.5 vs 0%), and prolonged operative time (7.9 ± 2.4 vs 6.9 ± 2.1 hr) in AIOD patients. In contrast, CS returns ≥1250 cc were relatively uncommon (28.6% AAA, 5.3% AIOD), and predictors of these CS returns were found only for AAA patients and included any concomitant vascular procedures (38.8 vs 15.6%) and the need for suprarenal aortic clamping (27.8 vs 6.7%). Despite the use of the CS, 73.8% of all patients required allogenic packed red blood cells with a mean of 3.0 ± 3.1 units transfused in the perioperative period; no difference was seen between AAA and AIOD patients. The calculated cost for a unit of CS return was $128.77 for the AAA patients and $231.91 for the AIOD patients. Not using the CS and substituting the return with allogenic packed red blood cells would have saved $252.80 and $352.84 for the AAA and AIOD patients, respectively. Routine use of the CS during elective infrarenal aortic reconstructions is not cost efficient and should be abandoned. Use of the device should be reserved only for complex reconstruction.

References (0)

Cited by (18)

  • The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm

    2018, Journal of Vascular Surgery
    Citation Excerpt :

    Although preoperative autologous blood donation avoids disease transmission and transfusion reaction as well as stimulates erythropoiesis, limitations include limited availability of blood donation, increased expense, and potential waste of nonused blood.565 Intraoperative cell salvage assists in blood conservation, has been recommended if large blood loss is anticipated, and may be helpful where concerns of the safety of banked blood exist.566-568 A prospective randomized trial of cell salvage in elective cardiac surgery did not lead to a reduction in exposure to allogeneic blood but did reduce the number of transfused units.569

  • Surgical Treatment of Abdominal Aortic Aneurysms

    2013, Vascular Medicine: A Companion to Braunwald's Heart Disease: Second Edition
  • The role of cell salvage autotransfusion in abdominal aortic aneurysm surgery

    2011, European Journal of Vascular and Endovascular Surgery
    Citation Excerpt :

    None of the three studies reported above mentioned the use of blood products other than red cells. Five uncontrolled studies have recorded blood-product use with routine use of a CS with very different outcomes (Table 1).39–43 Kelly-Patteson et al. prospectively studied 40 patients undergoing elective infrarenal AAA repairs by a single surgeon with a transfusion threshold of Hb < 8 g dl−1.39

  • Intraoperative Use of Cell Saver on Patients Undergoing Open Abdominal Aortic Aneurysm Surgical Repair: A Greek Hospital Experience

    2011, Journal of Perianesthesia Nursing
    Citation Excerpt :

    IAT is actualized through the use of cell saver machines built for the purpose of decreasing allogenic transfusions, conserving blood bank resources, and reducing the risk of transfusion-associated infections. Furthermore, these devices provide a readily available source of blood during excessive bleeding.7–9 Divergent views exist on the cost-effectiveness of IAT.

  • Recombinant Activated Factor VII: A Solution to Refractory Haemorrhage in Vascular Surgery?

    2008, European Journal of Vascular and Endovascular Surgery
    Citation Excerpt :

    Excessive blood loss, and blood product transfusion requirements, are two key independent predictors of outcome in major vascular surgery patients.3,4 Research into haemorrhage reduction in this setting includes the use of antifibrinolytics (e.g. aprotinin) and intra-operative autologous transfusion devices.5–7 However these have met with limited results.

View all citing articles on Scopus
View full text